1.73% 0.60

Invesco Nasdaq Biotechnology Etf (IBBQ)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Finanzdaten der Invesco Nasdaq Biotechnology Etf-Aktie (IBBQ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate
Revenues	8.24% 1,640.40	1,515.50
Operating Expenses	5.24% 1,369.50	1,301.30
Benefits Costs and Expenses	4.24% 1,293.70	1,241.10
Costs And Expenses	4.24% 1,293.70	1,241.10
Operating Income/Loss	26.47% 270.90	214.20
Income/Loss Before Equity Method Investments	25.06% 311.90	249.40
Income/Loss From Equity Method Investments	39.20% 34.80	25.00
Income/Loss From Continuing Operations Before Tax	26.35% 346.70	274.40
Income Tax Expense/Benefit	112.60% -9.70	77.00
Income/Loss From Continuing Operations After Tax	80.55% 356.40	197.40
Net Income/Loss	80.55% 356.40	197.40
Preferred Stock Dividends And Other Adjustments	21.55% 44.40	56.60
Attributable To Noncontrolling Interest	278.33% 10.70	-6.00
Basic Average Shares	0.31% 452.40	453.80
Diluted Average Shares	0.13% 454.60	455.20
Basic Earnings Per Share	2,333% 0.67	-0.03
Diluted Earnings Per Share	2,300% 0.66	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	21.55% 44.40	56.60